A regulatory and industrial perspective of the use of carbon-14 and tritium isotopes in human ADME studies
Pharm Res
.
1994 Jun;11(6):925-8.
doi: 10.1023/a:1018958631158.
Authors
J G Dain
1
,
J M Collins
,
W T Robinson
Affiliation
1
Department of Drug Metabolism and Pharmacokinetics, Sandoz Pharmaceuticals Corporation, E. Hanover, New Jersey 07936.
PMID:
7937538
DOI:
10.1023/a:1018958631158
No abstract available
MeSH terms
Adolescent
Adult
Carbon Radioisotopes*
Drug Industry / trends*
Female
Humans
Legislation, Drug / trends*
Male
Tritium*
United States
United States Food and Drug Administration
Substances
Carbon Radioisotopes
Tritium